The goal of geroscience, or research into old age, is to promote health during old age, and thus, to increase lifespan. In the body, the groups of biochemical reactions, or ‘pathways’, that allow an organism to sense nutrients, and regulate growth and stress, play major roles in ensuring healthy aging. Indeed, organisms that do not produce a working version of the insulin/IGF-1 receptor, a protein involved in one such pathway, show increased lifespan. In the worm Caenorhabditis elegans, mutations in the insulin/IGF-1 receptor can even double their lifespan. However, it is unclear whether this increase can be achieved once the organism has reached old age.

To answer this question, Venz et al. genetically engineered the nematode worm C. elegans so that they could trigger the rapid degradation of the insulin/IGF-1 receptor either in the entire organism or in a specific tissue. Venz et al. started by aging several C. elegans worms for three weeks, until about 75% had died. At this point, they triggered the degradation of the insulin/IGF-1 receptor in some of the remaining worms, keeping the rest untreated as a control for the experiment.

The results showed that the untreated worms died within a few days, while worms in which the insulin/IGF-1 receptor had been degraded lived for almost one more month. This demonstrates that it is possible to double the lifespan of an organism at the very end of life.

Venz et al.’s findings suggest that it is possible to make interventions to extend an organism’s lifespan near the end of life that are as effective as if they were performed when the organism was younger. This sparks new questions regarding the quality of this lifespan extension: do the worms become younger with the intervention, or is aging simply slowed down?

The goal of aging research or geroscience is to identify interventions that promote health during old age (Kennedy et al., 2014; López-Otín et al., 2013; Partridge et al., 2018). Nutrient-sensing pathways that regulate growth and stress resistance play major roles as conserved assurance pathways for healthy aging (Kenyon, 2010; López-Otín et al., 2013). One of the first longevity pathways discovered was the insulin/insulin-like growth factor (IGF)-1 signaling pathway (reviewed in Kenyon, 2010). Reducing insulin/IGF-1 signaling (IIS) increases lifespan across species (Kenyon, 2010). Mice heterozygous for the IGF-1 receptor, or with depleted insulin receptor in adipose tissue, are stress-resistant and long-lived (Blüher et al., 2003; Holzenberger et al., 2003), for example, and several single-nucleotide polymorphisms in the IIS pathway have been associated with human longevity (Kenyon, 2010). Moreover, gene variants in the IGF-1 receptor have been associated and functionally linked with long lifespans in human centenarians (Suh et al., 2008). This suggests that a comprehensive understanding of this pathway in experimental, genetically tractable organisms has promising translational value for promoting health in elderly humans. However, whether or not reducing IIS during end-of-life stages can still promote health and longevity in any organism is unknown. Therefore, we turned to the model organism Caenorhabditis elegans to investigate whether reducing IIS during old age was sufficient to increase lifespan.

The groundbreaking discovery that a single mutation in daf-2, which is the orthologue of both the insulin and IGF-1 receptors (Kimura et al., 1997), or mutations in ‘downstream’ genes in the IIS pathway, could double the lifespan of an organism was made in the nematode C. elegans (Friedman and Johnson, 1988; Kenyon et al., 1993). Since its discovery, over 1000 papers on daf-2 have been published, making it one of the most studied genes in this model organism (Source: PubMed). Genetic and genomics approaches have revealed that the DAF-2 insulin/IGF-1 receptor signaling regulates growth, development, metabolism, inter-tissue signaling, immunity, stress defense, and protein homeostasis, including extracellular matrix remodeling (Ewald et al., 2015; Gems et al., 1998; Kimura et al., 1997; Murphy and Hu, 2013; Wolkow et al., 2000). Much of our knowledge of the effects of daf-2 on aging has come from the study of reduction-of-function alleles of daf-2. Several alleles of daf-2 have been isolated that are temperature-sensitive with respect to an alternative developmental trajectory. For instance, most daf-2 mutants develop into adults at 15°C and 20°C but enter the dauer stage at 25°C (Gems et al., 1998), which is a facultative and alternative larval endurance stage in which C. elegans spends most of its life cycle in the wild (Hu, 2007). Under favorable conditions, C. elegans develops through four larval stages (L1–L4). By contrast, when the animals are deprived of food and experience an overcrowded environment and/or thermal stress (above 27°C), the developing larvae molt into an alternative pre-dauer (L2d) stage. If conditions do not improve, C. elegans enter the dauer diapause instead of the L3 stage (Golden and Riddle, 1984; Hu, 2007; Karp, 2018).

A major limitation in using daf-2 mutants is that several of them show L1 larval and pre-dauer stage (L2d) arrest (Gems et al., 1998). Furthermore, the daf-2 alleles have been categorized into two mutant classes depending on the penetrance of dauer-like phenotypes during adulthood, such as reduced brood size, small body size, and germline shrinkage, as observed in the daf-2 class II mutants (Arantes-Oliveira et al., 2003; Ewald et al., 2018; Ewald et al., 2015; Gems et al., 1998; Hess et al., 2019; Patel et al., 2008; Podshivalova and Kerr, 2017). RNA interference of daf-2 can be applied, which increases lifespan without dauer formation during development and circumvents induction of daf-2 class II mutant phenotypes during adulthood (Dillin et al., 2002; Ewald et al., 2018; Ewald et al., 2015; Kennedy et al., 2004). However, the increase in lifespan by RNAi of daf-2 is only partial compared to strong alleles such as daf-2(e1370) (Ewald et al., 2015). Furthermore, adult-specific RNAi knockdown of daf-2 quickly loses its potential to increase lifespan and does not extend lifespan when started after day 6 of adulthood (Dillin et al., 2002), that is, after the reproductive period of C. elegans. Whether this is due to age-related functional decline of RNAi machinery or residual DAF-2 protein levels, or whether the late-life depletion of daf-2 simply does not extend lifespan remains unclear. As such, using an alternative method to reduce DAF-2 levels beyond RNAi or daf-2 mutation may allow us to more clearly uncouple the pleiotropic effects of reduced IIS during development from those that drive daf-2-mediated longevity during late adulthood.

To this end, we used an auxin-inducible degradation (AID) system to induce the depletion of the degron-tagged DAF-2 protein with temporal precision (Zhang et al., 2015). The Arabidopsis thaliana IAA17 degron is a 68-amino acid motif that is specifically recognized by the transport inhibitor response 1 (TIR1) protein only in the presence of the plant hormone auxin (indole-3-acetic acid; Dharmasiri et al., 2005). Although cytoplasmic, nuclear, and membrane-binding proteins tagged with degron have been recently shown to be targeted and degraded in C. elegans (Beer et al., 2019; Zhang et al., 2015), to our knowledge, the AID system has not been used previously to degrade transmembrane proteins, such as the DAF-2 insulin/IGF-1 receptor. We find that using AID effectively degrades DAF-2 protein and promotes dauer formation when applied early in development. Dauer-like phenotypes are present in adults when AID of DAF-2 is applied late in development. Some of these adulthood dauer traits are induced by the loss of daf-2 in neurons, but others seem to be caused by the systemic loss of daf-2. More importantly, the post-developmental, conditional degradation of DAF-2 protein extends lifespan without introducing dauer-like phenotypes. Remarkably, we demonstrate that when more than half of the population has died at day 25 of adulthood, AID of DAF-2 in these remaining aged animals is sufficient to promote longevity. Our work suggests that therapeutics applied at even extremely late stages of life are capable of increasing longevity and healthspan in animals.

For longevity interventions to be efficient without causing undesired side effects, the time point of treatment must be chosen carefully. This is especially important for pathways such as the insulin/IGF-1 pathway that is essential for growth and development (Kenyon, 2010). Although the importance of DAF-2 in regulating lifespan is well established, the consequences of late-in-life inhibition remained unknown.

Here, we demonstrate that late-life degradation of DAF-2 extends lifespan. In this work, we have effectively engineered a degron tag into the endogenous daf-2 locus using CRISPR, representing the first report of auxin-induced degradation (AID) of a transmembrane receptor in vivo. DAF-2 receptor levels were strongly reduced via AID. Consistent with reduced insulin signaling, AID-mediated degradation of DAF-2 facilitated dauer formation, longevity, stress resistance, caused growth-related phenotypes during early adulthood, and finally increased longevity during the post-reproductive geriatric stages of life.

It is well established that DAF-2/insulin/IGF-1 receptor signaling connects nutrient levels to growth and development (Murphy and Hu, 2013). This is attributed to insulin-like peptides binding DAF-2 and activating a downstream phosphorylation kinase cascade that alters metabolism (Murphy and Hu, 2013). Surprisingly, we find that DAF-2 receptor abundance is linked to nutrient availability and perhaps dietary content. Starving C. elegans leads to decreased DAF-2 receptor abundance, consistent with previous in situ antibody staining (Kimura et al., 2011), whereas mimicking a high-energy diet by adding glucose to the bacterial food source increases DAF-2 receptor abundance. This suggests an additional layer of regulating IIS by connecting food cues to adapt metabolism via DAF-2 receptor levels, potentially as an internal representation of the environment.

Environmental conditions are carefully monitored by developing C. elegans. First, larval stage (L1) wild-type C. elegans that are food-deprived, exposed to elevated temperatures (>27°C), and/or are crowded, enter into a pre-dauer L2d stage, where they continue monitoring their environment before committing and molting into dauers (Hu, 2007; Karp, 2018). However, previous temperature-shifting experiments (from 15°C to 25°C) with daf-2 mutants have indicated the existence of a ‘dauer decision time window’ between the L1 and L2 stage (Swanson and Riddle, 1981). By using AID to manipulate DAF-2 levels directly, we found that AID degradation of DAF-2 during a narrow time period in the mid-L1 stage is sufficient to induce dauer formation, suggesting that the decision to enter dauer relies upon a threshold of DAF-2 protein levels. This decision is uncoupled from temperature or food abundance. Thus, absolute DAF-2 protein abundance appears to be a key factor in the animal’s decision to enter into the dauer state during early development.

Although IIS is reduced in daf-2(e1370 or e1368) mutants at lower temperatures (Ewald et al., 2018; Gems et al., 1998), dauer larvae are formed only when these daf-2 mutants are exposed to higher temperatures. The observation that mutant DAF-2 protein (Kimura et al., 2011) but not wild-type DAF-2 protein (Figure 5) is lost at elevated temperatures suggests a model where DAF-2 mutant protein becomes unstable with increasing temperatures and might be subsequently targeted for degradation. This hypothesis might explain why strong class II daf-2 mutants, such as daf-2(e979) and daf-2(e1391), which have much lower DAF-2 protein levels at 15°C and 25°C compared to other daf-2 mutants (Tawo et al., 2017), exhibit higher propensities toward dauer formation at any temperature (Gems et al., 1998). Thus, the severity of classical daf-2 mutant alleles in regard to dauer formation and adult dauer traits might be linked to DAF-2 receptor abundance.

At higher temperatures, adult daf-2 class II mutants exhibit significant penetrance of undesired phenotypes (Ewald et al., 2018). In these animals, a clear remodeling of the body and internal organs, including constriction of the pharynx and shrinkage of the germline, remains present, along with an altered neuronal morphology and electrical synapse connectome that drives behavioral changes such as quiescence, diminished foraging behavior, and altered egg-laying programs (Arantes-Oliveira et al., 2003; Ewald et al., 2015; Gems et al., 1998; Hess et al., 2019; Bhattacharya et al., 2019; Patel et al., 2008; Podshivalova and Kerr, 2017). We showed that L4-specific AID of the DAF-2::degron results in a non-conditional reduction of body size and brood size, whereas egg retention and germline shrinkage only occur at higher temperatures. This indicates that the non-conditional daf-2 class II traits are not a residual effect of a dauer-like developmental program but instead are side effects caused by reduced functions of DAF-2 during later stages of development.

Additional temperature-sensitive daf-2 class II traits of egg retention and gonad shrinkage are mediated by loss of daf-2 in neurons only at higher temperatures. Why these traits only manifest at higher temperatures remains unclear. One explanation may be that DAF-2 levels are reduced in temperature-sensing neurons, which then elicits a systemic effect that drives germline shrinkage and egg retention. Neurons are refractory to RNAi, suggesting that daf-2(RNAi) effects work through other tissues than neurons to extend lifespan. Furthermore, treating class I mutants daf-2(e1368) with daf-2(RNAi) doubles their longevity without causing adult daf-2 class II traits (Arantes-Oliveira et al., 2003), suggesting that daf-2(RNAi) would lower DAF-2 receptor levels in other tissues than neurons for this additive longevity effect.

Consistent with neuronal regulation of these traits is that daf-2 RNAi applied to wild type does not result in dauers but results in dauer formation when applied to neuronal-hypersensitive RNAi C. elegans strains (Dillin et al., 2002; Ewald et al., 2015; Kennedy et al., 2004). We find that DAF-2 degradation in neurons or intestine increases lifespan. This is consistent with a previous finding by Apfeld and Kenyon that either mosaic loss of daf-2 in AB cell lineage that gives rise to neurons and other cells (epidermis, seam, pharyngeal, vulval cells) or loss of daf-2 in EMS cell lineage that gives rise to intestinal and other cells (pharyngeal and gonadal cells) results in increased lifespan (Apfeld and Kenyon, 1998). By contrast, our neuronal DAF-2 depletion did not result in a doubling of lifespan as seen by loss of daf-2 in the AB lineage (Apfeld and Kenyon, 1998), suggesting that loss of daf-2 in other tissues, in combination with neurons or intestine, is required to recapitulate full lifespan extension. Given that reducing DAF-2 in neurons results in daf-2 class II traits at higher temperatures, one might target intestinal DAF-2 for degradation to uncouple longevity from any undesired phenotypes. Yet, DAF-2 is essential for growth. We find the best time point for DAF-2 inhibition is rather late in life to bypass these undesired side effects to promote longevity.

We find that as late as day 25 of adulthood, when almost three-quarters of the population had died, AID of DAF-2 is sufficient to increase lifespan. The only other manipulation that was able to increase the lifespan so late in life was the transfer of old C. elegans to culture plates without food (Smith et al., 2008). However, C. elegans do not feed after reaching mid-life (Collins et al., 2008; Ewald et al., 2016), suggesting that it might not be the intake of calories that promotes longevity. Instead, the old C. elegans could sense the absence of food and thereby reduce DAF-2 levels to promote longevity. Along these lines, it would be interesting to determine if late-life bacterial deprivation works synergistically with DAF-2 AID or not in future studies.

In mammals, mid-life administration of IGF-1 receptor monoclonal antibodies to 78-week-old mice (a time when all mice are still alive and 6 weeks before first mice start to die) is sufficient to increase their lifespan and improve their healthspan (Mao et al., 2018). Other parallels between mammals and nematodes are the tissues from which lower insulin/IGF-1 receptor levels promote longevity. Mice carrying brain-specific heterozygous IGF-1 receptor knockout are long-lived (Kappeler et al., 2008), as are the mice with adipose-specific knockout of the insulin receptor (Blüher et al., 2003). This is reminiscent of our findings that AID of DAF-2::degron in neurons or intestine (the major fat-storage tissue in C. elegans) was sufficient to increase the lifespan. These similarities could reflect conserved functions, as daf-2 is considered the common ancestor to both insulin and IGF-1 receptors (Kimura et al., 1997).

Although it is known that neurons and the intestine are important for food perception and regulation of food intake, the effects of food perception or intake on insulin receptor and IGF-1 receptor levels are poorly understood. Starving rats for 3 days increases the abundance of insulin-bound insulin receptors (Koopmans et al., 1995), possibly to increase glucose uptake. It is unknown whether prolonged starvation would lead to lower basal insulin/IGF-1 receptor levels. However, alterations of the IGF-1 receptor levels are associated with altered lifespan. For instance, heterozygous IGF-1 receptor knockout mice, which have lower IGF-1 receptor levels, have an increased lifespan (Holzenberger et al., 2003; Kappeler et al., 2008; Xu et al., 2014). Also, overexpression of the short isoform of p53 (p44) increases IGF-1 receptor levels and shortens the lifespan of mice (Maier et al., 2004). Furthermore, the administration of recombinant human IGF-1 increases IGF-1 receptor abundance in murine embryonic cells (Maier et al., 2004). Food components themselves can affect insulin receptor levels. For instance, palmitate activates PPARα to induce miR-15b, which targets insulin receptor mRNA for degradation (Li et al., 2019). Potentially, food components could impact the murine insulin/IGF-1 receptor also via its degradation.

Indeed, there is some evidence suggesting the regulation of insulin/IGF-1 receptor abundance by E3 ubiquitin ligases. For instance, the E3 ligase CHIP regulates insulin/IGF-1 receptor levels in C. elegans, Drosophila, and human cell cultures (Tawo et al., 2017). In mice, the muscle-specific mitsugumin 53 (MG53) E3 ligase targets the insulin receptor for degradation (Song et al., 2013). High-fat diet results in the reduction of insulin receptor levels (Li et al., 2019) via higher MG53-mediated degradation (Song et al., 2013). MG53 is upregulated under a high-fat diet in mice, and MG53-/- deficient mice are protected from high-fat diet-induced obesity, insulin resistance, and other metabolic syndrome-associated phenotypes (Song et al., 2013). Furthermore, another E3 ligase, MARCH1, is overexpressed in obese humans and targets the insulin receptor for ubiquitin-mediated degradation (Nagarajan et al., 2016). Taken together, these observations suggest that food abundance controls mammalian insulin receptor levels via E3 ligase-mediated degradation. Although in C. elegans we found the opposite changes in DAF-2 receptor levels, that is, they were reduced upon starvation and increased upon high glucose feeding, our observations suggest that nutritional cues may regulate insulin/IGF-1 receptor levels via a variety of mechanisms, including ubiquitination and proteasomal degradation, across species.

In summary, we have demonstrated that interventions at almost the end of life can increase lifespan. We have established that auxin-induced degradation is suitable for targeting transmembrane receptors for non-invasive manipulations during developmental and longevity in vivo studies. We reconciled a longstanding question by providing evidence that dauer-like traits are not a spill-over of reprogrammed physiology from developing L2d pre-dauers. Instead, the essential growth-related functions of DAF-2 are causing deficits when applied during development or growth phases. We have shown that tissue-specific interventions or global interventions beyond reproduction or growth extend lifespan without pathology or deficits. Degradation of DAF-2/insulin/IGF-1 receptor might not be an artificial intervention since DAF-2/insulin/IGF-1 receptor abundance is read-out to adapt metabolism to food abundance. Dissecting intrinsic DAF-2/insulin/IGF-1 receptor abundance in response to nutritional cues may impact our understanding of nutrient sensing in promoting health during old age.

Source Data 1 includes data for all figures, Source Data 2 shows all full western blots and Source Data 3 contains raw data for all arsenite stress assays.

1. 1. Aghayeva U
   2. Bhattacharya A
   3. Sural S
   4. Jaeger E
   5. Churgin M
   6. Fang-Yen C
   7. Hobert O

   (2021) DAF-16/FOXO and DAF-12/VDR control cellular plasticity both cell-autonomously and via interorgan signaling

   PLOS Biology 19:e3001204.

   https://doi.org/10.1371/journal.pbio.3001204

   • PubMed
   • Google Scholar
2. Book

   1. Altun ZF
   2. Hall DH

   (2002) WormAtlas Hermaphrodite Handbook - Epithelial System - Hypodermis

   Wormatlas.

   https://doi.org/10.3908/wormatlas.1.13

   • Google Scholar
3. 1. Apfeld J
   2. Kenyon C

   (1998) Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span

   Cell 95:199–210.

   https://doi.org/10.1016/s0092-8674(00)81751-1

   • PubMed
   • Google Scholar
4. 1. Arantes-Oliveira N
   2. Berman JR
   3. Kenyon CJ

   (2003) Healthy animals with extreme longevity

   Science 302:611.

   https://doi.org/10.1126/science.1089169

   • PubMed
   • Google Scholar
5. 1. Beer KB
   2. Fazeli G
   3. Judasova K
   4. Irmisch L
   5. Causemann J
   6. Mansfeld J
   7. Wehman AM

   (2019) Degron-tagged reporters probe membrane topology and enable the specific labelling of membrane-wrapped structures

   Nature Communications 10:3490.

   https://doi.org/10.1038/s41467-019-11442-z

   • PubMed
   • Google Scholar
6. 1. Bhattacharya A
   2. Aghayeva U
   3. Berghoff EG
   4. Hobert O

   (2019) Plasticity of the electrical connectome of C. elegans

   Cell 176:1174–1189.

   https://doi.org/10.1016/j.cell.2018.12.024

   • PubMed
   • Google Scholar
7. 1. Blüher M
   2. Kahn BB
   3. Kahn CR

   (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue

   Science 299:572–574.

   https://doi.org/10.1126/science.1078223

   • PubMed
   • Google Scholar
8. 1. Collins JJ
   2. Huang C
   3. Hughes S
   4. Kornfeld K

   (2008) The measurement and analysis of age-related changes in Caenorhabditis elegans

   WormBook 1:1–21.

   https://doi.org/10.1895/wormbook.1.137.1

   • PubMed
   • Google Scholar
9. 1. Dharmasiri N
   2. Dharmasiri S
   3. Estelle M

   (2005) The f-box protein tir1 is an auxin receptor

   Nature 435:441–445.

   https://doi.org/10.1038/nature03543

   • PubMed
   • Google Scholar
10. 1. Dillin A
    2. Crawford DK
    3. Kenyon CJ

    (2002) Timing requirements for insulin/igf-1 signaling in C. elegans

    Science 298:830–834.

    https://doi.org/10.1126/science.1074240

    • PubMed
    • Google Scholar
11. 1. Ewald CY
    2. Raps DA
    3. Li C

    (2012) APL-1, the Alzheimer’s Amyloid precursor protein in Caenorhabditis elegans, modulates multiple metabolic pathways throughout development

    Genetics 191:493–507.

    https://doi.org/10.1534/genetics.112.138768

    • PubMed
    • Google Scholar
12. 1. Ewald CY
    2. Landis JN
    3. Porter Abate J
    4. Murphy CT
    5. Blackwell TK

    (2015) Dauer-independent insulin/igf-1-signalling implicates collagen remodelling in longevity

    Nature 519:97–101.

    https://doi.org/10.1038/nature14021

    • PubMed
    • Google Scholar
13. 1. Ewald CY
    2. Marfil V
    3. Li C

    (2016) Alzheimer-related protein APL-1 modulates lifespan through heterochronic gene regulation in Caenorhabditis elegans

    Aging Cell 15:1051–1062.

    https://doi.org/10.1111/acel.12509

    • PubMed
    • Google Scholar
14. 1. Ewald CY
    2. Hourihan JM
    3. Blackwell TK

    (2017a) Oxidative stress assays (arsenite and TBHP) in Caenorhabditis elegans

    Bio-Protocol 7:e2365.

    https://doi.org/10.21769/bioprotoc.2365

    • PubMed
    • Google Scholar
15. 1. Ewald CY
    2. Hourihan JM
    3. Bland MS
    4. Obieglo C
    5. Katic I
    6. Moronetti Mazzeo LE
    7. Alcedo J
    8. Blackwell TK
    9. Hynes NE

    (2017b) NADPH oxidase-mediated redox signaling promotes oxidative stress resistance and longevity through memo-1 in C. elegans

    eLife 6:e19493.

    https://doi.org/10.7554/eLife.19493

    • PubMed
    • Google Scholar
16. 1. Ewald CY
    2. Castillo-Quan JI
    3. Blackwell TK

    (2018) Untangling longevity, dauer, and healthspan in Caenorhabditis elegans insulin/igf-1-signalling

    Gerontology 64:96–104.

    https://doi.org/10.1159/000480504

    • PubMed
    • Google Scholar
17. 1. Friedman DB
    2. Johnson TE

    (1988) A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility

    Genetics 118:75–86.

    https://doi.org/10.1093/genetics/118.1.75

    • PubMed
    • Google Scholar
18. 1. Frøkjaer-Jensen C
    2. Davis MW
    3. Hopkins CE
    4. Newman BJ
    5. Thummel JM
    6. Olesen SP
    7. Grunnet M
    8. Jorgensen EM

    (2008) Single-copy insertion of transgenes in Caenorhabditis elegans

    Nature Genetics 40:1375–1383.

    https://doi.org/10.1038/ng.248

    • PubMed
    • Google Scholar
19. 1. Frøkjær-Jensen C
    2. Davis MW
    3. Ailion M
    4. Jorgensen EM

    (2012) Improved mos1-mediated transgenesis in C. elegans

    Nature Methods 9:117–118.

    https://doi.org/10.1038/nmeth.1865

    • PubMed
    • Google Scholar
20. 1. Gems D
    2. Sutton AJ
    3. Sundermeyer ML
    4. Albert PS
    5. King KV
    6. Edgley ML
    7. Larsen PL
    8. Riddle DL

    (1998) Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans

    Genetics 150:129–155.

    https://doi.org/10.1093/genetics/150.1.129

    • PubMed
    • Google Scholar
21. 1. Gibson DG
    2. Young L
    3. Chuang RY
    4. Venter JC
    5. Hutchison CA
    6. Smith HO

    (2009) Enzymatic assembly of DNA molecules up to several hundred kilobases

    Nature Methods 6:343–345.

    https://doi.org/10.1038/nmeth.1318

    • PubMed
    • Google Scholar
22. 1. Golden JW
    2. Riddle DL

    (1984) The Caenorhabditis elegans dauer larva: developmental effects of pheromone, food, and temperature

    Developmental Biology 102:368–378.

    https://doi.org/10.1016/0012-1606(84)90201-x

    • PubMed
    • Google Scholar
23. 1. Han S
    2. Schroeder EA
    3. Silva-García CG
    4. Hebestreit K
    5. Mair WB
    6. Brunet A

    (2017) Mono-unsaturated fatty acids link h3k4me3 modifiers to C. elegans lifespan

    Nature 544:185–190.

    https://doi.org/10.1038/nature21686

    • PubMed
    • Google Scholar
24. 1. Henderson ST
    2. Johnson TE

    (2001)

    Daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans

    CURBIO 11:1975–1980.

    • Google Scholar
25. 1. Hess M
    2. Gomariz A
    3. Goksel O
    4. Ewald CY

    (2019) In-vivo quantitative image analysis of age-related morphological changes of C. elegans neurons reveals a correlation between neurite bending and novel neurite outgrowths

    ENeuro 6:ENEURO.0014-19.2019.

    https://doi.org/10.1523/eneuro.0014-19.2019

    • PubMed
    • Google Scholar
26. 1. Holzenberger M
    2. Dupont J
    3. Ducos B
    4. Leneuve P
    5. Géloën A
    6. Even PC
    7. Cervera P
    8. Le Bouc Y

    (2003) Igf-1 receptor regulates lifespan and resistance to oxidative stress in mice

    Nature 421:182–187.

    https://doi.org/10.1038/nature01298

    • PubMed
    • Google Scholar
27. 1. Hu PJ

    (2007) Dauer

    WormBook 1:1–19.

    https://doi.org/10.1895/wormbook.1.144.1

    • PubMed
    • Google Scholar
28. 1. Hubbard EJA
    2. Greenstein D

    (2000) The Caenorhabditis elegans gonad: a test tube for cell and developmental biology

    Developmental Dynamics 218:2–22.

    https://doi.org/10.1002/(SICI)1097-0177(200005)218:1<2::AID-DVDY2>3.0.CO;2-W

    • PubMed
    • Google Scholar
29. 1. Kappeler L
    2. De Magalhaes Filho C
    3. Dupont J
    4. Leneuve P
    5. Cervera P
    6. Périn L
    7. Loudes C
    8. Blaise A
    9. Klein R
    10. Epelbaum J
    11. Le Bouc Y
    12. Holzenberger M

    (2008) Brain igf-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism

    PLOS Biology 6:e254.

    https://doi.org/10.1371/journal.pbio.0060254

    • PubMed
    • Google Scholar
30. 1. Karp X

    (2018) Working with Dauer larvae

    WormBook 2018:1–19.

    https://doi.org/10.1895/wormbook.1.180.1

    • PubMed
    • Google Scholar
31. 1. Katic I
    2. Xu L
    3. Ciosk R

    (2015) Crispr/cas9 genome editing in Caenorhabditis elegans: Evaluation of templates for homology-mediated repair and knock-ins by homology-independent DNA repair

    G3: Genes, Genomes, Genetics 5:1649–1656.

    https://doi.org/10.1534/g3.115.019273

    • PubMed
    • Google Scholar
32. 1. Kennedy S
    2. Wang D
    3. Ruvkun G

    (2004) A conserved sirna-degrading rnase negatively regulates RNA interference in C. elegans

    Nature 427:645–649.

    https://doi.org/10.1038/nature02302

    • PubMed
    • Google Scholar
33. 1. Kennedy BK
    2. Berger SL
    3. Brunet A
    4. Campisi J
    5. Cuervo AM
    6. Epel ES
    7. Franceschi C
    8. Lithgow GJ
    9. Morimoto RI
    10. Pessin JE
    11. Rando TA
    12. Richardson A
    13. Schadt EE
    14. Wyss-Coray T
    15. Sierra F

    (2014) Geroscience: Linking aging to chronic disease

    Cell 159:709–713.

    https://doi.org/10.1016/j.cell.2014.10.039

    • PubMed
    • Google Scholar
34. 1. Kenyon CJ
    2. Chang J
    3. Gensch E
    4. Rudner A
    5. Tabtiang R

    (1993) A C. elegans mutant that lives twice as long as wild type

    Nature 366:461–464.

    https://doi.org/10.1038/366461a0

    • PubMed
    • Google Scholar
35. 1. Kenyon CJ

    (2010) The genetics of ageing

    Nature 464:504–512.

    https://doi.org/10.1038/nature08980

    • PubMed
    • Google Scholar
36. 1. Kimura KD
    2. Tissenbaum HA
    3. Liu Y
    4. Ruvkun G

    (1997) Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans

    Science 277:942–946.

    https://doi.org/10.1126/science.277.5328.942

    • PubMed
    • Google Scholar
37. Conference

    1. Kimura KD
    2. Riddle DL
    3. Ruvkun G

    (2011) Cold Spring Harbor Symposia on Quantitative Biology

    The C. elegans DAF-2 insulin-like receptor is abundantly expressed in the nervous system and regulated by nutritional status. pp. 113–120.

    https://doi.org/10.1101/sqb.2011.76.010660

    • Google Scholar
38. 1. Koopmans SJ
    2. Maassen JA
    3. Sips HCM
    4. Radder JK
    5. Krans HMJ

    (1995) Tissue-related changes in insulin receptor number and autophosphorylation induced by starvation and diabetes in rats

    Metabolism 44:291–297.

    https://doi.org/10.1016/0026-0495(95)90157-4

    • Google Scholar
39. 1. Li W-D
    2. Xia J-R
    3. Lian Y-S

    (2019) MIR-15B can target insulin receptor to regulate hepatic insulin signaling in mice

    Animal Cells and Systems 23:82–89.

    https://doi.org/10.1080/19768354.2019.1583125

    • PubMed
    • Google Scholar
40. 1. Lin K
    2. Hsin H
    3. Libina N
    4. Kenyon CJ

    (2001) Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling

    Nature Genetics 28:139–145.

    https://doi.org/10.1038/88850

    • PubMed
    • Google Scholar
41. 1. Lopez AL
    2. Chen J
    3. Joo HJ
    4. Drake M
    5. Shidate M
    6. Kseib C
    7. Arur S

    (2013) DAF-2 and ERK couple nutrient availability to meiotic progression during Caenorhabditis elegans oogenesis

    Developmental Cell 27:227–240.

    https://doi.org/10.1016/j.devcel.2013.09.008

    • PubMed
    • Google Scholar
42. 1. López-Otín C
    2. Blasco MA
    3. Partridge L
    4. Serrano M
    5. Kroemer G

    (2013) The hallmarks of aging

    Cell 153:1194–1217.

    https://doi.org/10.1016/j.cell.2013.05.039

    • PubMed
    • Google Scholar
43. 1. Maier B
    2. Gluba W
    3. Bernier B
    4. Turner T
    5. Mohammad K
    6. Guise T
    7. Sutherland A
    8. Thorner M
    9. Scrable H

    (2004) Modulation of mammalian life span by the short isoform of p53

    Genes & Development 18:306–319.

    https://doi.org/10.1101/gad.1162404

    • PubMed
    • Google Scholar
44. 1. Mainpal R
    2. Nance J
    3. Yanowitz JL

    (2015) A novel germ cell determinant reveals parallel pathways for germ line development in Caenorhabditis elegans

    Development 142:3571–3582.

    https://doi.org/10.1242/dev.125732

    • PubMed
    • Google Scholar
45. 1. Malone EA
    2. Thomas JH

    (1994) A screen for nonconditional dauer-constitutive mutations in Caenorhabditis elegans

    Genetics 136:879–886.

    https://doi.org/10.1093/genetics/136.3.879

    • PubMed
    • Google Scholar
46. 1. Mao K
    2. Quipildor GF
    3. Tabrizian T
    4. Novaj A
    5. Guan F
    6. Walters RO
    7. Delahaye F
    8. Hubbard GB
    9. Ikeno Y
    10. Ejima K
    11. Li P
    12. Allison DB
    13. Salimi-Moosavi H
    14. Beltran PJ
    15. Cohen P
    16. Barzilai N
    17. Huffman DM

    (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice

    Nature Communications 9:2394.

    https://doi.org/10.1038/s41467-018-04805-5

    • PubMed
    • Google Scholar
47. 1. McCulloch D
    2. Gems D

    (2003) Body size, insulin/igf signaling and aging in the nematode Caenorhabditis elegans

    Experimental Gerontology 38:129–136.

    https://doi.org/10.1016/s0531-5565(02)00147-x

    • PubMed
    • Google Scholar
48. 1. Murphy CT
    2. McCarroll SA
    3. Bargmann CI
    4. Fraser A
    5. Kamath RS
    6. Ahringer J
    7. Li H
    8. Kenyon CJ

    (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans

    Nature 424:277–283.

    https://doi.org/10.1038/nature01789

    • PubMed
    • Google Scholar
49. 1. Murphy CT
    2. Hu PJ

    (2013) Insulin/insulin-like growth factor signaling in C. elegans

    WormBook 1:1–43.

    https://doi.org/10.1895/wormbook.1.164.1

    • PubMed
    • Google Scholar
50. 1. Nagarajan A
    2. Petersen MC
    3. Nasiri AR
    4. Butrico G
    5. Fung A
    6. Ruan HB
    7. Kursawe R
    8. Caprio S
    9. Thibodeau J
    10. Bourgeois-Daigneault MC
    11. Sun L
    12. Gao G
    13. Bhanot S
    14. Jurczak MJ
    15. Green MR
    16. Shulman GI
    17. Wajapeyee N

    (2016) MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels

    Nature Communications 7:12639.

    https://doi.org/10.1038/ncomms12639

    • PubMed
    • Google Scholar
51. 1. Ogg S
    2. Paradis S
    3. Patterson GI
    4. Ruvkun G

    (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans

    Nature 389:994–999.

    https://doi.org/10.1038/40194

    • PubMed
    • Google Scholar
52. 1. Partridge L
    2. Deelen J
    3. Slagboom PE

    (2018) Facing up to the global challenges of ageing

    Nature 561:45–56.

    https://doi.org/10.1038/s41586-018-0457-8

    • PubMed
    • Google Scholar
53. 1. Patel DS
    2. Garza-Garcia A
    3. Nanji M
    4. McElwee JJ
    5. Ackerman D
    6. Driscoll PC
    7. Gems D

    (2008) Clustering of genetically defined allele classes in the Caenorhabditis elegans DAF-2 insulin/IGF-1 receptor

    Genetics 178:931–946.

    https://doi.org/10.1534/genetics.107.070813

    • PubMed
    • Google Scholar
54. 1. Pierce SB
    2. Costa M
    3. Wisotzkey R
    4. Devadhar S
    5. Homburger SA
    6. Buchman AR
    7. Ferguson KC
    8. Heller J
    9. Platt DM
    10. Pasquinelli AA
    11. Liu LX
    12. Doberstein SK
    13. Ruvkun G

    (2001) Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family

    Gene Dev 15:672–686.

    https://doi.org/10.1101/gad.867301

    • PubMed
    • Google Scholar
55. 1. Podshivalova K
    2. Kerr RA

    (2017) How a mutation that slows aging can also disproportionately extend End-of-Life decrepitude

    Cell Reports 19:441–450.

    https://doi.org/10.1016/j.celrep.2017.03.062

    • PubMed
    • Google Scholar
56. 1. Schwartz ML
    2. Jorgensen EM

    (2016) SapTrap, a Toolkit for High-Throughput CRISPR/Cas9 Gene Modification in Caenorhabditis elegans

    Genetics 202:1277–1288.

    https://doi.org/10.1534/genetics.115.184275

    • PubMed
    • Google Scholar
57. 1. Smith ED
    2. Kaeberlein TL
    3. Lydum BT
    4. Sager J
    5. Welton KL
    6. Kennedy BK
    7. Kaeberlein M

    (2008) Age- and calorie-independent life span extension from dietary restriction by bacterial deprivation in Caenorhabditis elegans

    BMC Developmental Biology 8:13–49.

    https://doi.org/10.1186/1471-213x-8-49

    • PubMed
    • Google Scholar
58. 1. Song R
    2. Peng W
    3. Zhang Y
    4. Lv F
    5. H-K W
    6. Guo J
    7. Cao Y
    8. Pi Y
    9. Xin Z
    10. Jin L
    11. Zhang M
    12. Peng J
    13. Liu F
    14. Meng S
    15. Xiuqin Z
    16. Ping J
    17. Cao CM
    18. Xiao RP

    (2013) Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders

    Nature 494:375–379.

    https://doi.org/10.1038/nature11834

    • PubMed
    • Google Scholar
59. 1. Suh Y
    2. Atzmon G
    3. Cho MO
    4. Hwang D
    5. Liu B
    6. Leahy DJ
    7. Barzilai N
    8. Cohen P

    (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians

    PNAS 105:3438–3442.

    https://doi.org/10.1073/pnas.0705467105

    • PubMed
    • Google Scholar
60. 1. Swanson MM
    2. Riddle DL

    (1981) Critical periods in the development of the Caenorhabditis elegans dauer larva

    Developmental Biology 84:27–40.

    https://doi.org/10.1016/0012-1606(81)90367-5

    • PubMed
    • Google Scholar
61. 1. Tawo R
    2. Pokrzywa W
    3. Kevei É
    4. Akyuz ME
    5. Balaji V
    6. Adrian S
    7. Höhfeld J
    8. Hoppe T

    (2017) The ubiquitin ligase chip integrates proteostasis and aging by regulation of insulin receptor turnover

    Cell 169:470–482.

    https://doi.org/10.1016/j.cell.2017.04.003

    • PubMed
    • Google Scholar
62. 1. Teuscher AC
    2. Ewald CY

    (2018) Overcoming autofluorescence to assess GFP expression during normal physiology and aging in Caenorhabditis elegans

    BIO-PROTOCOL 8:e2940.

    https://doi.org/10.21769/bioprotoc.2940

    • PubMed
    • Google Scholar
63. 1. Teuscher AC
    2. Statzer C
    3. Pantasis S
    4. Bordoli MR
    5. Ewald CY

    (2019) Assessing collagen deposition during aging in mammalian tissue and in Caenorhabditis elegans

    Methods Mol Biology Clifton N J1944:169–188.

    https://doi.org/10.1007/978-1-4939-9095-5_13

    • PubMed
    • Google Scholar
64. 1. Tomioka M
    2. Naito Y
    3. Kuroyanagi H
    4. Iino Y

    (2016) Splicing factors control C. elegans behavioural learning in a single neuron by producing DAF-2c receptor

    Nature Communications 7:11645.

    https://doi.org/10.1038/ncomms11645

    • PubMed
    • Google Scholar
65. 1. Tullet JMA
    2. Hertweck M
    3. Baker J
    4. Hwang JY
    5. Liu S
    6. Oliveira RP
    7. Baumeister R
    8. Blackwell TK

    (2008) Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans

    Cell 132:1025–1038.

    https://doi.org/10.1016/j.cell.2008.01.030

    • PubMed
    • Google Scholar
66. 1. Wolkow CA
    2. Kimura KD
    3. Lee MS
    4. Ruvkun G

    (2000) Regulation of C. elegans life-span by insulinlike signaling in the nervous system

    Science 290:147–150.

    https://doi.org/10.1126/science.290.5489.147

    • PubMed
    • Google Scholar
67. 1. Xu J
    2. Gontier G
    3. Chaker Z
    4. Lacube P
    5. Dupont J
    6. Holzenberger M

    (2014) Longevity effect of IGF-1R(+/-) mutation depends on genetic background-specific receptor activation

    Aging Cell 13:19–28.

    https://doi.org/10.1111/acel.12145

    • PubMed
    • Google Scholar
68. 1. Zhang L
    2. Ward JD
    3. Cheng Z
    4. Dernburg AF

    (2015) The auxin-inducible degradation (AID) system enables versatile conditional protein depletion in C. elegans

    Development 142:4374–4384.

    https://doi.org/10.1242/dev.129635

    • PubMed
    • Google Scholar

Author details

1. Richard Venz

   Eidgenössische Technische Hochschule Zürich, Department of Health Sciences and Technology, Institute of Translational Medicine, Schwerzenbach-Zürich, Switzerland

   Contribution

   Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Performed all assays not listed by other authors. Wrote the manuscript with CYE in consultation with the other authors, Validation, Visualization, Writing – original draft

   Competing interests

   No competing interests declared

2. Tina Pekec

   1. University of Basel, Faculty of Natural Sciences, Basel, Switzerland
   2. Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland

   Contribution

   Investigation, Methodology, Crossed the DAF-2::degron strain and the transgenes into DAF-2::degron strain, Validation

   Competing interests

   No competing interests declared

3. Iskra Katic

   Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland

   Contribution

   Methodology, Writing – review and editing

   Competing interests

   No competing interests declared

4. Rafal Ciosk

   1. Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
   2. Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego, Poland
   3. University of Oslo, Department of Biosciences, Oslo, Norway

   Contribution

   Conceptualization, Funding acquisition, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-2234-6216

5. Collin Yvès Ewald

   Eidgenössische Technische Hochschule Zürich, Department of Health Sciences and Technology, Institute of Translational Medicine, Schwerzenbach-Zürich, Switzerland

   Contribution

   Performed late-in-life top-coating auxin lifespans. Wrote the manuscript with RV in consultation with the other authors, Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing

   For correspondence

   collin-ewald@ethz.ch

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-1166-4171

• 6,194

  Page views

• 669

  Downloads

• 22

  Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.